Krystal Biotech, Inc. (KRYS)
272.19
+5.29
(+1.98%)
USD |
NASDAQ |
Feb 25, 16:00
272.19
0.00 (0.00%)
After-Hours: 19:35
Krystal Biotech Profit Margin (Quarterly) : 47.99% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 0.91% |
| DexCom, Inc. | 21.22% |
| Alkermes Plc | 21.00% |
| Regeneron Pharmaceuticals, Inc. | 21.74% |
| Alnylam Pharmaceuticals, Inc. | 16.99% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 19.22% |
| Return on Assets | 17.53% |
| Return on Invested Capital | 19.06% |
| Gross Profit Margin (Quarterly) | 92.39% |
| Operating Margin (Quarterly) | 41.33% |
| Return on Net Operating Assets | 65.69% |